NCT00486356 2024-01-03
Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer
University of Nebraska
Phase 1 Completed
Clinical Trials
42 trialsNCT02287129 2023-11-28
MEMORI
Technical University of Munich
Phase 2 Completed
NCT02338518 2023-09-29
SVOSA
Jinling Hospital, China
Phase 3 Unknown
NCT05472896 2022-07-25
TACE With Dicycloplatin(TP21) in Unresectable HCC
Zhongda Hospital
Phase 3 Unknown
NCT02395640 2021-10-26
The Comparison of XELOX and EOX in the First-line Treatment of Advanced Gastric Cancer
Fudan University
Phase 3 Completed
NCT00381706 2021-09-29
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT05053386 2021-09-22
Idarubicin vs. Epirubicin TACE in the Treatment of Hepatocellular Carcinoma
Zhejiang Cancer Hospital
Phase NA Unknown
NCT02128243 2021-03-26
MATEO
AIO-Studien-gGmbH
Phase 2 Completed
NCT04738188 2021-02-04
Efficacy and Safety of TACE on Downstaging Hepatocellular Carcinoma Beyond UCSF Criteria;
Beijing Tsinghua Chang Gung Hospital
Phase NA Unknown
NCT02971345 2020-06-11
Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus
Shanghai Zhongshan Hospital
Phase 3 Unknown
NCT00052910 2020-05-07
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT02076594 2019-10-09
Low-Tox Vs Eox In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente
Phase 3 Terminated
NCT01216644 2019-06-19
5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer
Krankenhaus Nordwest
Phase 2/3 Completed
NCT02177552 2019-02-15
SEED
Rigshospitalet, Denmark
Phase 2 Unknown
NCT01386346 2018-12-12
VEOX
Weill Medical College of Cornell University
Phase 1 Completed
NCT03668418 2018-09-12
xenoZ
University of Pisa
Unknown
NCT02358863 2018-09-06
mEGA
Georgetown University
Phase NA Terminated
NCT01830270 2018-07-26
IPEC-GC
Centre Hospitalier Universitaire de Besancon
Phase 2 Terminated
NCT01234324 2018-01-23
NEOPECX
AIO-Studien-gGmbH
Phase 2 Completed
NCT03192644 2017-06-20
The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.
Sun Yat-sen University
Phase 3 Unknown
NCT02949258 2016-10-31
NCT-B4
Jinling Hospital, China
Phase 2 Unknown
NCT02630108 2016-10-18
TACE Combined With Synchronous Radiofrequency /Microwave Ablation to Treat Large and Huge Hepatocellular Carcinoma
Shanghai Zhongshan Hospital
Phase 3 Unknown
NCT01624025 2016-08-17
A Comparative Study of Salvage Treatment With Combination of Docetaxel and Epirubicin
Yonsei University
Phase 2 Completed
NCT02755311 2016-04-28
Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma
Sun Yat-sen University
Phase 3 Unknown
NCT00820053 2016-04-01
A Trial of Adjuvant Transarterial Chemoembolization (TACE) for Preventing Tumor Recurrence After Liver Resection
Eastern Hepatobiliary Surgery Hospital
Phase 2 Completed
NCT00130936 2016-02-15
Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates
AHS Cancer Control Alberta
Phase 1/2 Terminated
NCT00737438 2016-02-03
Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT02631499 2015-12-22
Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation
Fudan University
Phase 4 Unknown
NCT00718354 2015-05-13
GASTRANOX
Thrombosis Research Institute
Phase 3 Completed
NCT01167738 2015-04-24
PACT-17
IRCCS San Raffaele
Phase 2 Terminated
NCT00375999 2014-03-03
Docetaxel and Epirubicin in Advanced Gastric Cancer
Yonsei University
Phase 2 Completed
NCT01053390 2013-12-20
New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma
Shanghai Jiao Tong University School of Medicine
Phase 3 Completed
NCT01964027 2013-10-17
SIEG
Anhui Medical University
Phase 2 Unknown
NCT00123318 2013-06-18
A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer
Trans Tasman Radiation Oncology Group
Phase 3 Completed
NCT00824785 2012-12-11
REAL3
Royal Marsden NHS Foundation Trust
Phase 3 Terminated
NCT00843934 2012-10-19
ACE500
Nihon University
Phase 2/3 Unknown
NCT01327521 2012-06-11
Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma
Stanford University
Phase 3 Withdrawn
NCT00004873 2012-05-15
Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer
Swiss Cancer Institute
Phase 2 Completed
NCT00966706 2012-02-01
PACT-9
IRCCS San Raffaele
Phase 2 Completed
NCT00960284 2012-01-13
PACT-7
IRCCS San Raffaele
Phase 2/3 Completed
NCT00743964 2010-01-15
Phase II Study of Epirubicin, Cisplatin and Capecitabine (ECX) Versus Cisplatin and Capecitabine (CX) for Advanced Gastric Cancer (AGC)
Samsung Medical Center
Phase 2 Completed
NCT00220129 2009-12-16
Neoadjuvant Epirubicin, Cisplatin and Capecitabine (ECX) Followed by Definitive Chemoradiation With/Without Surgery for Squamous Cell Carcinoma of the Oesophagus
Royal Marsden NHS Foundation Trust
Phase 2 Completed